Nanomedicine News

RSS

RBCC-n3D JV Well-Positioned to Capitalize on Rise of 3D Printing in Medicine

As Rainbow Coral Corp. works to market and develop an innovative new 3D bioprinting system, new 3D printing innovations are generating massive new demand for the technology from patients and doctors alike in the medical industry.

24 Feb 2014

NanoViricides’ Modern R&D Lab and cGMP Clinical Production Facility in Shelton Nears Completion

NanoViricides, Inc. (the "Company") reported today that construction of the modern R&D Lab and cGMP Clinical Production facility in Shelton, CT, is nearing completion with some weather-related delays. The Company reports that the R&D lab section of the facility is ahead of schedule. Once construction of the cGMP Clean Room Production Suite is completed, the project will enter the facility testing and validation phase.

From NanoViricides, Inc 21 Feb 2014

Specially Designed Nanovalves in Nanoparticles Control Release of Anticancer Drugs

Researchers from the cancer nanotechnology and signal transduction and therapeutics programs of UCLA’s Jonsson Comprehensive Cancer Center (JCCC) have developed an innovative technique that can carry chemotherapy safely and release it inside cancer cells when triggered by two-photon laser in the infrared red wave length.

From University of California, Los Angeles 21 Feb 2014

Global Industry Analysis Report on Nanomedicine Market

Research and Markets has announced the addition of the "Nanomedicine Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" report to their offering.

From Research and Markets 20 Feb 2014

Novel Nanoparticles Deliver Drugs Targeting Damaged Arteries

Clemson University researchers have developed nanoparticles that can deliver drugs targeting damaged arteries, a non-invasive method to fight heart disease.

19 Feb 2014

Nanodiamonds Bound Together With Drugs and Embedded Onto Contact Lenses Help Improve Glaucoma Treatment

By 2020, nearly 80 million people are expected to have glaucoma, a disorder of the eye that, if left untreated, can damage the optic nerve and eventually lead to blindness.

From University of California, Los Angeles 19 Feb 2014

Novel Nanotherapeutic Approach for Co-Targeting Melanoma Cells and Astrocytes

Tel Aviv University researchers won two out of three prestigious melanoma research awards granted this year by The Melanoma Research Alliance (MRA) and The Saban Family Foundation. The Team Science Awards are the centerpiece of the MRA research fund, which seeks to promote transformational melanoma research for swift clinical implementation.

19 Feb 2014